We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
PURITAN MEDICAL

Download Mobile App




Stem Cell and 3D Printing Generate Viable Tissue

By LabMedica International staff writers
Posted on 11 May 2017
A team of Swedish cell biologists combined three-dimensional (3D) bio-printing with advanced stem cell technology to create viable cultures of cartilage tissue that had cellular and mechanical properties similar to patients’ natural cartilage.

Cartilage lesions can progress into secondary osteoarthritis and cause severe clinical problems in numerous patients. More...
To fill and cure such lesions, investigators at the University of Gothenburg developed a novel class of stem cells that could survive being injected by a three-dimensional printing method and then mature into functional cartilage tissue.

The investigators began with cartilage cells taken from patients undergoing knee surgery. These cells were then manipulated in a laboratory and transformed into induced pluripotent stem cells. The stem cells were expanded and encapsulated in a solution of nanofibrillated cellulose and printed into a structure using a three-dimensional (3D) bio-printer. Following printing, the stem cells were treated with growth factors that caused them to differentiate into cartilage tissue.

Much of the research effort involved finding a procedure to enable the cells to survive printing and multiply and a protocol that induced the cells to differentiate to form cartilage.

Results published in the April 6, 2017, online edition of the journal Scientific Reports revealed that pluripotency was initially maintained, and after five weeks, hyaline-like cartilaginous tissue with collagen type II expression and lacking tumorigenic Oct4 expression was observed in the three-dimensional (3D)-bio-printed constructs. Moreover, a marked increase in cell number within the cartilaginous tissue was detected by 2-photon fluorescence microscopy, indicating the importance of high cell densities in the pursuit of achieving good survival after printing.

“In nature, the differentiation of stem cells into cartilage is a simple process, but it is much more complicated to accomplish in a test tube. We are the first to succeed with it, and we did so without any animal testing whatsoever," said senior author Dr. Stina Simonsson, associate professor of cell biology at the University of Gothenburg. "We investigated various methods and combined different growth factors. Each individual stem cell is encased in nanocellulose, which allows it to survive the process of being printed into a three-dimensional (3D) structure. We also harvested media from other cells that contain the signals that stem cells use to communicate with each other - so called conditioned medium. In layman’s terms, our theory is that we managed to trick the cells into thinking that they are not alone.”


Gold Member
Flocked Fiber Swabs
Puritan® Patented HydraFlock®
3-Part Differential Hematology Analyzer
Swelab Alfa Plus Sampler
New
Automated Microscope
dIFine
New
Integrated Biochemical & Immunological System
Biolumi CX8
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








DIASOURCE (A Biovendor Company)

Channels

Molecular Diagnostics

view channel
Image: The RNA-seq based diagnostic test for pediatric leukemia ensures better outcomes for children with this common cancer (Photo courtesy of Qlucore)

RNA-Seq Based Diagnostic Test Enhances Diagnostic Accuracy of Pediatric Leukemia

A new unique test is set to reshape the way Acute Lymphoblastic Leukemia (BCP-ALL) samples can be analyzed. Qlucore (Lund, Sweden) has launched the first CE-marked RNA-seq based diagnostic test for pediatric... Read more

Hematology

view channel
Image: CitoCBC is the world first cartridge-based CBC to be granted CLIA Waived status by FDA (Photo courtesy of CytoChip)

Disposable Cartridge-Based Test Delivers Rapid and Accurate CBC Results

Complete Blood Count (CBC) is one of the most commonly ordered lab tests, crucial for diagnosing diseases, monitoring therapies, and conducting routine health screenings. However, more than 90% of physician... Read more

Immunology

view channel
Image: A simple blood test could replace surgical biopsies for early detecion of heart transplant rejection (Photo courtesy of Shutterstock)

Blood Test Detects Organ Rejection in Heart Transplant Patients

Following a heart transplant, patients are required to undergo surgical biopsies so that physicians can assess the possibility of organ rejection. Rejection happens when the recipient’s immune system identifies... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.